Key Market Indicator:
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 26.07.2023
Samara Asset Group plc
Samara Asset Group is actively ramping up its investments in the
fund-of-fund approach. Samara Alpha Management launches flagship fund,
promising attractive risk-adjusted returns.
In June 2023, Samara Asset Group (formerly: Cryptology Asset Group) sold
its entire stake in Block.one, a crypto company, for $118.9 million,
resulting in a prof [ … ]
Tue, 25.07.2023
Health Italia S.p.A.
“[…] we aim to strengthen our position as a leader in the healthcare
industry by prioritizing patient-centeredness, fostering innovation and
embracing digitization.”
This management interview features Livia Foglia, the CEO of Health Italia
S.p.A. GBC will soon initiate research coverage on Health Italia, and the
co [ … ]
Tue, 25.07.2023
Health Italia S.p.A.
“[…] we aim to strengthen our position as a leader in the healthcare
industry by prioritizing patient-centeredness, fostering innovation and
embracing digitization.”
This management interview features Livia Foglia, the CEO of Health Italia
S.p.A. GBC will soon initiate research coverage on Health Italia, and the
co [ … ]
Mon, 17.07.2023
UmweltBank AG
- Transformation process 'umwelt.neo' makes the Bank future proof
- Two transitional years expected
- Growth is expected again from 2025 onwards
In the past financial year 2022, UmweltBank AG was able to further expand
its business volume to € 6,602.1 million (31.12.21: € 6,451.0 million),
even in a difficult market environment. [ … ]
Mon, 17.07.2023
UmweltBank AG
- Transformation process 'umwelt.neo' makes the Bank future proof
- Two transitional years expected
- Growth is expected again from 2025 onwards
In the past financial year 2022, UmweltBank AG was able to further expand
its business volume to € 6,602.1 million (31.12.21: € 6,451.0 million),
even in a difficult market environment. [ … ]
Fri, 14.07.2023
Coreo AG
- FY 2022 was marked by portfolio optimisation
- Postponed investments should be realised in 2024
- Break-even expected from 2024
In the past financial year 2022, Coreo AG's focus was on active asset
management of the existing portfolio, whereas no new investments were made
for the first time since the start of real estate-related business [ … ]
Fri, 14.07.2023
Coreo AG
- FY 2022 was marked by portfolio optimisation
- Postponed investments should be realised in 2024
- Break-even expected from 2024
In the past financial year 2022, Coreo AG's focus was on active asset
management of the existing portfolio, whereas no new investments were made
for the first time since the start of real estate-related business [ … ]
Fri, 14.07.2023
HAEMATO AG
- Compulsory manufacturer discounts burden 'Specialty Pharma' segment
- Lifestyle & Aesthetics' segment should grow in 2023; high potentials
available with Botox launch
- Increase in profitability expected
As expected, HAEMATO AG reports a decline in revenue to € 248.14 million
(previous year: € 285.04 million) for the past f [ … ]
Fri, 14.07.2023
HAEMATO AG
- Compulsory manufacturer discounts burden 'Specialty Pharma' segment
- Lifestyle & Aesthetics' segment should grow in 2023; high potentials
available with Botox launch
- Increase in profitability expected
As expected, HAEMATO AG reports a decline in revenue to € 248.14 million
(previous year: € 285.04 million) for the past f [ … ]
Wed, 12.07.2023
Advanced Blockchain AG
Considerable upside potential to portfolio valuation. Track record of
successful partial divestments and financing rounds.
In 2022, Advanced Blockchain AG expanded its portfolio by investing in 12
promising blockchain projects and Web3 infrastructure initiatives. Also
three in-house portfolio companies secured over $53 million in funding f [ … ]